Evidence map›Paper›PMID 35654978›Full record

ArticleNature biotechnology2022

Spatiotemporal multiplexed immunofluorescence imaging of living cells and tissues with bioorthogonal cycling of fluorescent probes.

Jina Ko, Martin Wilkovitsch, Juhyun Oh, Rainer H Kohler, Evangelia Bolli, Mikael J Pittet, Claudio Vinegoni, David B Sykes, Hannes Mikula, Ralph Weissleder and 1 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Single-Cell Protein Assays in Context: From 2D to 3D and In Situ Analysis.Annual review of analytical chemistry (Palo Alto, Calif.) · 2026
    Review
  4. Article
  5. Dynamic Decoration of DNA Scaffolds for High-Resolution Cancer Cell Subtyping.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Synthesis of CThe Journal of organic chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jina KoCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.
Martin WilkovitschInstitute of Applied Synthetic Chemistry, TU Wien, Vienna, Austria.ORCID http://orcid.org/0000-0002-6809-6972
Juhyun OhCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.
Rainer H KohlerCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6269-6590
Evangelia BolliCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.
Mikael J PittetCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2060-4691
Claudio VinegoniCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9818-3639
David B SykesCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9788-0221
Hannes MikulaInstitute of Applied Synthetic Chemistry, TU Wien, Vienna, Austria.ORCID http://orcid.org/0000-0002-9218-9722
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA. rweissleder@mgh.harvard.edu.ORCID http://orcid.org/0000-0003-0828-4143
Jonathan C T CarlsonCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA. carlson.jonathan@mgh.harvard.edu.ORCID http://orcid.org/0000-0003-4139-9057

Funding

The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CARTER, BOB S · 1996 to 2021
$30.9M
Strategies to Overcome Immune Resistance in Head and Neck CancersP01CA240239 · NCI · YALE UNIVERSITY · PI MEMPEL, THORSTEN ROMAN · 2019 to 2023
$8.4M
FAST-FNA immune cell profiling in HNSCCR01CA257623 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FAQUIN, WILLIAM CLAY, WEISSLEDER, MD, PHD, RALPH · 2021 to 2025
$3.3M
Clinical platform for high-throughput analyses of extracellular vesiclesR01CA229777 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO, SKOG, JOHAN · 2018 to 2022
$3.2M
Imaging of nanotherapeutic drug actionU01CA206997 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2017 to 2021
$2.9M
Smartphone for molecular cancer diagnostic in AfricaUH3CA202637 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHABNER, BRUCE ALLAN, WEISSLEDER, MD, PHD, RALPH · 2018 to 2020
$2.9M
Imaging tumor associated macrophage (TAM) functionR01CA206890 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PITTET, MIKAEL, WEISSLEDER, MD, PHD, RALPH · 2017 to 2021
$1.9M
Bioorthogonal probe development for highly parallel in vivo imagingR33CA277820 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2023 to 2025
$1.2M
Mapping Single Extracellular Vesicles to Parent Cells for Immunotherapy MonitoringR00CA256353 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KO, JINA · 2022 to 2024
$741k
Mapping Single Extracellular Vesicles to Parent Cells for Immunotherapy MonitoringK99CA256353 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI KO, JINA · 2021 to 2021
$178k
NCI NIH HHS K99 CA256353NCI NIH HHS P01 CA069246NCI NIH HHS P01 CA240239NCI NIH HHS R00 CA256353NCI NIH HHS R01 CA206890NCI NIH HHS R01 CA229777NCI NIH HHS R01 CA257623NCI NIH HHS R33 CA277820NCI NIH HHS U01 CA206997NCI NIH HHS UH3 CA202637
6 · The paper itself

Abstract

Cells in complex organisms undergo frequent functional changes, but few methods allow comprehensive longitudinal profiling of living cells. Here we introduce scission-accelerated fluorophore exchange (SAFE), a method for multiplexed temporospatial imaging of living cells with immunofluorescence. SAFE uses a rapid bioorthogonal click chemistry to remove immunofluorescent signals from the surface of labeled cells, cycling the nanomolar-concentration reagents in seconds and enabling multiple rounds of staining of the same samples. It is non-toxic and functional in both dispersed cells and intact living tissues. We demonstrate multiparameter (n ≥ 14), non-disruptive imaging of murine peripheral blood mononuclear and bone marrow cells to profile cellular differentiation. We also show longitudinal multiplexed imaging of bone marrow progenitor cells as they develop into neutrophils over 6 days and real-time multiplexed cycling of living mouse hepatic tissues. We anticipate that SAFE will find broad utility for investigating physiologic dynamics in living systems.

Indexed as

Fluorescent DyesLeukocytes, MononuclearAnimalsFluorescent Antibody TechniqueMiceOptical ImagingStaining and LabelingFluorescent Dyes

Identifiers

PMID35654978
PMCPMC9669087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.